BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36631634)

  • 1. A liquid biopsy signature for predicting early recurrence in patients with gastric cancer.
    Okuno K; Watanabe S; Roy S; Kanda M; Tokunaga M; Kodera Y; Kinugasa Y; Goel A
    Br J Cancer; 2023 Apr; 128(6):1105-1116. PubMed ID: 36631634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the Diagnostic Efficiency of a Liquid Biopsy Assay for Early Detection of Gastric Cancer.
    Izumi D; Zhu Z; Chen Y; Toden S; Huo X; Kanda M; Ishimoto T; Gu D; Tan M; Kodera Y; Baba H; Li W; Chen J; Wang X; Goel A
    JAMA Netw Open; 2021 Aug; 4(8):e2121129. PubMed ID: 34427680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Transcriptomic Liquid Biopsy Assay for Predicting Resistance to Neoadjuvant Therapy in Esophageal Squamous Cell Carcinoma.
    Okuno K; Tokunaga M; Kinugasa Y; Baba H; Kodera Y; Goel A
    Ann Surg; 2022 Jul; 276(1):101-110. PubMed ID: 35703443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide identification of a novel miRNA-based signature to predict recurrence in patients with gastric cancer.
    Yang Y; Qu A; Zhao R; Hua M; Zhang X; Dong Z; Zheng G; Pan H; Wang H; Yang X; Zhang Y
    Mol Oncol; 2018 Dec; 12(12):2072-2084. PubMed ID: 30242969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic efficacy of circular RNAs as noninvasive, liquid biopsy biomarkers for early detection of gastric cancer.
    Roy S; Kanda M; Nomura S; Zhu Z; Toiyama Y; Taketomi A; Goldenring J; Baba H; Kodera Y; Goel A
    Mol Cancer; 2022 Feb; 21(1):42. PubMed ID: 35139874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomewide Expression Profiling Identifies a Novel miRNA-based Signature for the Detection of Peritoneal Metastasis in Patients With Gastric Cancer.
    Shimura T; Toden S; Kandimalla R; Toiyama Y; Okugawa Y; Kanda M; Baba H; Kodera Y; Kusunoki M; Goel A
    Ann Surg; 2021 Nov; 274(5):e425-e434. PubMed ID: 31663973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptomic Profiling Identifies a Risk Stratification Signature for Predicting Peritoneal Recurrence and Micrometastasis in Gastric Cancer.
    Lee IS; Lee H; Hur H; Kanda M; Yook JH; Kim BS; Woo Y; Kodera Y; Kim K; Goel A
    Clin Cancer Res; 2021 Apr; 27(8):2292-2300. PubMed ID: 33558424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
    Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
    Front Immunol; 2022; 13():947802. PubMed ID: 36405735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
    Zhang C; Zhang CD; Ma MH; Dai DQ
    World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and validation of an expression signature for recurrence prediction in high-risk diffuse-type gastric cancer.
    Lee IS; Sahu D; Hur H; Yook JH; Kim BS; Goel A
    Gastric Cancer; 2021 May; 24(3):655-665. PubMed ID: 33523340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma microRNA-based signatures to predict 3-year postoperative recurrence risk for stage II and III gastric cancer.
    Liu X; Zhang X; Zhang Z; Chang J; Wang Z; Wu Z; Wang C; Sun Z; Ge X; Geng R; Tang W; Dai C; Lin Y; Lin F; Sun M; Jia W; Xue W; Ji J; Hu Y; Qin G; Li J
    Int J Cancer; 2017 Nov; 141(10):2093-2102. PubMed ID: 28722210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and external validation of a novel miRNA signature for lymph node metastasis prediction in submucosal-invasive gastric cancer patients.
    Ma M; Lu S; Liu Y; Kong P; Long Z; Wan P; Zhang Y; Wang Y; Xu D
    Cancer Med; 2019 Oct; 8(14):6315-6325. PubMed ID: 31486298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Liquid Biopsy Assay for Noninvasive Identification of Lymph Node Metastases in T1 Colorectal Cancer.
    Wada Y; Shimada M; Murano T; Takamaru H; Morine Y; Ikemoto T; Saito Y; Balaguer F; Bujanda L; Pellise M; Kato K; Saito Y; Ikematsu H; Goel A
    Gastroenterology; 2021 Jul; 161(1):151-162.e1. PubMed ID: 33819484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptomic Profiling Identifies an Exosomal microRNA Signature for Predicting Recurrence Following Surgery in Patients With Pancreatic Ductal Adenocarcinoma.
    Nishiwada S; Cui Y; Sho M; Jun E; Akahori T; Nakamura K; Sonohara F; Yamada S; Fujii T; Han IW; Tsai S; Kodera Y; Park JO; Von Hoff D; Kim SC; Li W; Goel A
    Ann Surg; 2022 Dec; 276(6):e876-e885. PubMed ID: 34132691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A blood-based transcriptomic signature for noninvasive diagnosis of gastric cancer.
    Lee IS; Ahn J; Kim K; Okugawa Y; Toiyama Y; Hur H; Goel A
    Br J Cancer; 2021 Sep; 125(6):846-853. PubMed ID: 34163003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Liquid Biopsy Signature for the Detection of Patients With Early-Onset Colorectal Cancer.
    Nakamura K; Hernández G; Sharma GG; Wada Y; Banwait JK; González N; Perea J; Balaguer F; Takamaru H; Saito Y; Toiyama Y; Kodera Y; Boland CR; Bujanda L; Quintero E; Goel A
    Gastroenterology; 2022 Nov; 163(5):1242-1251.e2. PubMed ID: 35850198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
    World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and Validation of Salivary Extracellular RNA Biomarkers for Noninvasive Detection of Gastric Cancer.
    Li F; Yoshizawa JM; Kim KM; Kanjanapangka J; Grogan TR; Wang X; Elashoff DE; Ishikawa S; Chia D; Liao W; Akin D; Yan X; Lee MS; Choi R; Kim SM; Kang SY; Bae JM; Sohn TS; Lee JH; Choi MG; Min BH; Lee JH; Kim JJ; Kim Y; Kim S; Wong DTW
    Clin Chem; 2018 Oct; 64(10):1513-1521. PubMed ID: 30097497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating miRNA Signature Predicts Response to Preoperative Chemoradiotherapy in Locally Advanced Rectal Cancer.
    Wada Y; Shimada M; Morine Y; Ikemoto T; Saito Y; Zhu Z; Wang X; Etxart A; Park Y; Bujanda L; Park IJ; Goel A
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34913022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive and Prognostic Value of an MicroRNA Signature for Gastric Carcinoma Undergoing Adjuvant Chemotherapy.
    Cheng X; Wei H; Zhang S; Zhang F
    DNA Cell Biol; 2021 Nov; 40(11):1428-1444. PubMed ID: 34767733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.